The primary mechanism of action for fibrates is the upregulation of lipoprotein lipase, which leads to increased breakdown of triglycerides in the blood. Additionally, they enhance the oxidation of fatty acids in the liver and muscles. These actions collectively result in decreased levels of triglycerides and modest increases in HDL cholesterol. However, the activation of PPARs also presents a risk for hepatotoxicity and other adverse effects.
